NCT06247722View on ClinicalTrials.gov

Real World Use of Tocilizumab Biosimilar studY

Active, not recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

March 5, 2024

Primary Completion Date

March 5, 2026

Study Completion Date

March 31, 2026

Conditions
Rheumatoid Arthritis
Trial Locations (8)

12161

Rheumatologische Schwerpunktpraxis Berlin, Berlin

14467

Rheumahaus Potsdam, Potsdam

14974

Facharztpraxis für Innere Medizin Ludwigsfelde, Ludwigsfelde

17268

Rheumatologische Facharztpraxis Templin, Templin

39104

Rheumatologische Facharztpraxis, Magdeburg

82152

Klinische Forschung, Planegg

06128

Rheumapraxis Dr. Liebhaber Halle, Halle

06618

Facharztpraxis für Innere Medizin, Naumburg

All Listed Sponsors
lead

Fresenius Kabi SwissBioSim GmbH

INDUSTRY

NCT06247722 - Real World Use of Tocilizumab Biosimilar studY | Biotech Hunter | Biotech Hunter